# Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans

> **NCT03287765** · — · COMPLETED · sponsor: **Tammie L. S. Benzinger, MD, PhD** · enrollment: 54 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** 18F-AV-1451

## Key facts

- **NCT ID:** NCT03287765
- **Lead sponsor:** Tammie L. S. Benzinger, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2021-05
- **Final completion:** 2021-07-19
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03287765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03287765, "Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03287765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*